tiprankstipranks
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market
APRE
Aprea Therapeutics
RESEARCH TOOLSreports

Aprea Therapeutics (APRE) Stock News & Sentiment

499 Followers
Aprea Therapeutics: Positive Read‑Through From Zentalis and Improving WEE1 Sentiment Support Buy Rating and $5 Target
Premium
Ratings
Aprea Therapeutics: Positive Read‑Through From Zentalis and Improving WEE1 Sentiment Support Buy Rating and $5 Target
1d ago
APRE
Aprea Therapeutics Raises $30M to Advance Oncology Pipeline
Premium
Company Announcements
Aprea Therapeutics Raises $30M to Advance Oncology Pipeline
14d ago
8K
APRE
Aprea Therapeutics Announces $30 Million Private Placement
Premium
Company Announcements
Aprea Therapeutics Announces $30 Million Private Placement
16d ago
8K
APRE
Aprea Highlights Early APR-1051 Data and Financial Update
Premium
Company Announcements
Aprea Highlights Early APR-1051 Data and Financial Update
1M ago
8K
APRE
Aprea Therapeutics: Emerging Dose-Responsive Efficacy and Favorable Safety of APR-1051 Underpin Buy Rating
Premium
Ratings
Aprea Therapeutics: Emerging Dose-Responsive Efficacy and Favorable Safety of APR-1051 Underpin Buy Rating
2M ago
APRE
Aprea Highlights Encouraging Phase 1 Data for APR-1051
Premium
Company Announcements
Aprea Highlights Encouraging Phase 1 Data for APR-1051
2M ago
8K
APRE
APR-1051’s Emerging Best-in-Class WEE1 Profile Underpins Buy Rating on Aprea Therapeutics
Premium
Ratings
APR-1051’s Emerging Best-in-Class WEE1 Profile Underpins Buy Rating on Aprea Therapeutics
2M ago
APRE
More APRE News >

APRE News on the Web

Aprea Therapeutics: Positive Read‑Through From Zentalis and Improving WEE1 Sentiment Support Buy Rating and $5 Target
TipRanks News
Bullish
Maxim Group Reaffirms Their Buy Rating on Aprea Therapeutics (APRE)
TipRanks News
Bullish
Aprea Therapeutics Closes Oversubscribed $30 Mln Private Placement; Stock Down
rttnews
Bearish
Aprea Therapeutics Raises $30M to Advance Oncology Pipeline
TipRanks News
Neutral
Aprea Therapeutics price target lowered to $1.20 from $4 at H.C. Wainwright
TipRanks News
Bearish
Aprea Therapeutics Announces $30 Million Private Placement
TipRanks News
Neutral
Aprea Reports Confirmed Partial Response In APR-1051 Trial And Announced $30M Private Placement
rttnews
Bullish
Aprea Therapeutics confirms partial response in ongoing ACESOT-1051 trial
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
APRE
Sector Average
Media Buzz
This Week1 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is APRE’s Media Buzz Sentiment?
1 articles about APRE were published this week. In an average week, 2 articles are published.
    What is APRE’s weekly average amount of articles?
    In an average week, 2 articles about APRE are published.
      What is APRE’s News Sentiment?
      100% of articles about APRE were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        GLMDGalmed Pharmaceuticals
        ALLOAllogene Therapeutics
        TXTMProText Mobility
        REPLReplimune Group
        IVVDInvivyd
        Showing the stocks with the most bullish news sentiment over the past week